FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:TP53-PXDNL

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: TP53-PXDNL
FusionPDB ID: 93236
FusionGDB2.0 ID: 93236
HgeneTgene
Gene symbol

TP53

PXDNL

Gene ID

7157

137902

Gene nametumor protein p53peroxidasin like
SynonymsBCC7|BMFS5|LFS1|P53|TRP53PMR1|PRM1|VPO2
Cytomap

17p13.1

8q11.22-q11.23

Type of geneprotein-codingprotein-coding
Descriptioncellular tumor antigen p53antigen NY-CO-13mutant tumor protein 53p53 tumor suppressorphosphoprotein p53transformation-related protein 53tumor protein 53tumor supressor p53peroxidasin-like proteincardiac peroxidasecardiovascular peroxidase 2peroxidasin homolog-likepolysomal ribonuclease 1 homologvascular peroxidase 2
Modification date2020032920200313
UniProtAcc

Q12888

Main function of 5'-partner protein: FUNCTION: Double-strand break (DSB) repair protein involved in response to DNA damage, telomere dynamics and class-switch recombination (CSR) during antibody genesis (PubMed:12364621, PubMed:22553214, PubMed:23333306, PubMed:17190600, PubMed:21144835, PubMed:27153538, PubMed:28241136). Plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs and specifically counteracting the function of the homologous recombination (HR) repair protein BRCA1 (PubMed:22553214, PubMed:23727112, PubMed:23333306, PubMed:27153538). In response to DSBs, phosphorylation by ATM promotes interaction with RIF1 and dissociation from NUDT16L1/TIRR, leading to recruitment to DSBs sites (PubMed:28241136). Recruited to DSBs sites by recognizing and binding histone H2A monoubiquitinated at 'Lys-15' (H2AK15Ub) and histone H4 dimethylated at 'Lys-20' (H4K20me2), two histone marks that are present at DSBs sites (PubMed:23760478, PubMed:27153538, PubMed:28241136, PubMed:17190600). Required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (PubMed:23345425). Participates in the repair and the orientation of the broken DNA ends during CSR (By similarity). In contrast, it is not required for classic NHEJ and V(D)J recombination (By similarity). Promotes NHEJ of dysfunctional telomeres via interaction with PAXIP1 (PubMed:23727112). {ECO:0000250|UniProtKB:P70399, ECO:0000269|PubMed:12364621, ECO:0000269|PubMed:17190600, ECO:0000269|PubMed:21144835, ECO:0000269|PubMed:22553214, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:23345425, ECO:0000269|PubMed:23727112, ECO:0000269|PubMed:23760478, ECO:0000269|PubMed:27153538, ECO:0000269|PubMed:28241136}.
.
Ensembl transtripts involved in fusion geneENST idsENST00000269305, ENST00000359597, 
ENST00000413465, ENST00000420246, 
ENST00000445888, ENST00000455263, 
ENST00000574684, 
ENST00000356297, 
ENST00000543296, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score30 X 19 X 10=57007 X 5 X 8=280
# samples 379
** MAII scorelog2(37/5700*10)=-3.94536474342315
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(9/280*10)=-1.63742992061529
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: TP53 [Title/Abstract] AND PXDNL [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: TP53 [Title/Abstract] AND PXDNL [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)TP53(7577499)-PXDNL(52567320), # samples:1
Anticipated loss of major functional domain due to fusion event.TP53-PXDNL seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
TP53-PXDNL seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
TP53-PXDNL seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
TP53-PXDNL seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
TP53-PXDNL seems lost the major protein functional domain in Hgene partner, which is a cell metabolism gene due to the frame-shifted ORF.
TP53-PXDNL seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF.
TP53-PXDNL seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF.
TP53-PXDNL seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
TP53-PXDNL seems lost the major protein functional domain in Hgene partner, which is a transcription factor due to the frame-shifted ORF.
TP53-PXDNL seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF.
TP53-PXDNL seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneTP53

GO:0000733

DNA strand renaturation

8183576

HgeneTP53

GO:0006355

regulation of transcription, DNA-templated

7587074

HgeneTP53

GO:0006974

cellular response to DNA damage stimulus

14744935|15710329|17938203

HgeneTP53

GO:0006978

DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator

16213212

HgeneTP53

GO:0006983

ER overload response

14744935

HgeneTP53

GO:0007050

cell cycle arrest

15149599

HgeneTP53

GO:0008104

protein localization

16507995

HgeneTP53

GO:0008285

negative regulation of cell proliferation

22783376

HgeneTP53

GO:0010628

positive regulation of gene expression

15314173|20332243

HgeneTP53

GO:0030330

DNA damage response, signal transduction by p53 class mediator

15149599

HgeneTP53

GO:0031497

chromatin assembly

16322561

HgeneTP53

GO:0034644

cellular response to UV

16213212|23629966

HgeneTP53

GO:0036003

positive regulation of transcription from RNA polymerase II promoter in response to stress

30089260

HgeneTP53

GO:0042149

cellular response to glucose starvation

14744935|21471221

HgeneTP53

GO:0042771

intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator

14654789|14744935|17403783

HgeneTP53

GO:0042981

regulation of apoptotic process

14744935

HgeneTP53

GO:0043065

positive regulation of apoptotic process

12667443|15565177|20959462

HgeneTP53

GO:0045892

negative regulation of transcription, DNA-templated

24051492

HgeneTP53

GO:0045893

positive regulation of transcription, DNA-templated

16322561|17403783|18549481|20378837

HgeneTP53

GO:0045899

positive regulation of RNA polymerase II transcriptional preinitiation complex assembly

24289924

HgeneTP53

GO:0045944

positive regulation of transcription by RNA polymerase II

11672523|17145718|17310983|17599062|18549481|20959462|24652652

HgeneTP53

GO:0051123

RNA polymerase II preinitiation complex assembly

24289924

HgeneTP53

GO:0051974

negative regulation of telomerase activity

10597287

HgeneTP53

GO:0065003

protein-containing complex assembly

12915590

HgeneTP53

GO:0071158

positive regulation of cell cycle arrest

15314173

HgeneTP53

GO:0071480

cellular response to gamma radiation

16213212

HgeneTP53

GO:0072331

signal transduction by p53 class mediator

15314173

HgeneTP53

GO:0072717

cellular response to actinomycin D

15314173

HgeneTP53

GO:0090200

positive regulation of release of cytochrome c from mitochondria

14963330

HgeneTP53

GO:0097252

oligodendrocyte apoptotic process

7720704

HgeneTP53

GO:1902895

positive regulation of pri-miRNA transcription by RNA polymerase II

20546595

HgeneTP53

GO:1903800

positive regulation of production of miRNAs involved in gene silencing by miRNA

26100857

HgeneTP53

GO:1990248

regulation of transcription from RNA polymerase II promoter in response to DNA damage

30089260



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:7577499/chr8:52567320)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across TP53 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across PXDNL (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000413465TP53chr177577499-ENST00000356297PXDNLchr852567320-5322782050091669
ENST00000359597TP53chr177577499-ENST00000356297PXDNLchr852567320-5322782050091669
ENST00000269305TP53chr177577499-ENST00000543296PXDNLchr852567320-52619728547581557
ENST00000455263TP53chr177577499-ENST00000356297PXDNLchr852567320-54559152851421704
ENST00000420246TP53chr177577499-ENST00000356297PXDNLchr852567320-54559152851421704
ENST00000445888TP53chr177577499-ENST00000543296PXDNLchr852567320-52079183447041556

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000413465ENST00000356297TP53chr177577499-PXDNLchr852567320-0.0006309950.99936897
ENST00000359597ENST00000356297TP53chr177577499-PXDNLchr852567320-0.0006309950.99936897
ENST00000269305ENST00000543296TP53chr177577499-PXDNLchr852567320-0.0007331890.9992668
ENST00000455263ENST00000356297TP53chr177577499-PXDNLchr852567320-0.0007583380.9992417
ENST00000420246ENST00000356297TP53chr177577499-PXDNLchr852567320-0.0007583380.9992417
ENST00000445888ENST00000543296TP53chr177577499-PXDNLchr852567320-0.000710310.99928963

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for TP53-PXDNL

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
TP53chr177577499PXDNLchr852567320782260RRPILTIITLEDSRDLRFNRIREIPG
TP53chr177577499PXDNLchr852567320915295RRPILTIITLEDSRDLRFNRIREIPG
TP53chr177577499PXDNLchr852567320918294RRPILTIITLEDSRDLRFNRIREIPG
TP53chr177577499PXDNLchr852567320972295RRPILTIITLEDSRDLRFNRIREIPG

Top

Potential FusionNeoAntigen Information of TP53-PXDNL in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
TP53-PXDNL_7577499_52567320.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
TP53-PXDNLchr177577499chr852567320972HLA-B44:03LEDSRDLRF0.99170.8234918
TP53-PXDNLchr177577499chr852567320972HLA-B57:01ITLEDSRDLRF10.8771718
TP53-PXDNLchr177577499chr852567320972HLA-B57:03ITLEDSRDLRF0.99990.8419718
TP53-PXDNLchr177577499chr852567320972HLA-B15:17ITLEDSRDLRF0.99980.7863718
TP53-PXDNLchr177577499chr852567320972HLA-B58:01ITLEDSRDLRF0.99970.7356718
TP53-PXDNLchr177577499chr852567320972HLA-B15:16ITLEDSRDLRF0.99970.5124718
TP53-PXDNLchr177577499chr852567320972HLA-C03:08ITLEDSRDL0.99420.8985716
TP53-PXDNLchr177577499chr852567320972HLA-C03:07ITLEDSRDL0.9890.981716
TP53-PXDNLchr177577499chr852567320972HLA-B39:12SRDLRFNRI0.98650.53291221
TP53-PXDNLchr177577499chr852567320972HLA-C07:13SRDLRFNRI0.94610.76591221
TP53-PXDNLchr177577499chr852567320972HLA-B14:03SRDLRFNRI0.49230.5921221
TP53-PXDNLchr177577499chr852567320972HLA-B39:08LEDSRDLRF0.37020.583918
TP53-PXDNLchr177577499chr852567320972HLA-B44:07LEDSRDLRF0.99170.8234918
TP53-PXDNLchr177577499chr852567320972HLA-B44:26LEDSRDLRF0.99170.8234918
TP53-PXDNLchr177577499chr852567320972HLA-B44:13LEDSRDLRF0.99170.8234918
TP53-PXDNLchr177577499chr852567320972HLA-B39:31SRDLRFNRI0.98850.52861221
TP53-PXDNLchr177577499chr852567320972HLA-B18:11LEDSRDLRF0.95630.6801918
TP53-PXDNLchr177577499chr852567320972HLA-C18:01SRDLRFNRI0.90.67371221
TP53-PXDNLchr177577499chr852567320972HLA-C07:04SRDLRFNRI0.74120.88621221
TP53-PXDNLchr177577499chr852567320972HLA-C06:08SRDLRFNRI0.70970.9491221
TP53-PXDNLchr177577499chr852567320972HLA-C06:06SRDLRFNRI0.60250.96961221
TP53-PXDNLchr177577499chr852567320972HLA-C06:17SRDLRFNRI0.01810.96871221
TP53-PXDNLchr177577499chr852567320972HLA-C06:02SRDLRFNRI0.01810.96871221
TP53-PXDNLchr177577499chr852567320972HLA-B57:10ITLEDSRDLRF10.8771718
TP53-PXDNLchr177577499chr852567320972HLA-B57:04ITLEDSRDLRF10.5992718
TP53-PXDNLchr177577499chr852567320972HLA-B57:02ITLEDSRDLRF0.99990.7646718

Top

Potential FusionNeoAntigen Information of TP53-PXDNL in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
TP53-PXDNL_7577499_52567320.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
TP53-PXDNLchr177577499chr852567320972DRB1-0338DSRDLRFNRIREIPG1126
TP53-PXDNLchr177577499chr852567320972DRB1-0403RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0403RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0405RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0405RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0407RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0409RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0409RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0411RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0411RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0411PILTIITLEDSRDLR217
TP53-PXDNLchr177577499chr852567320972DRB1-0411ILTIITLEDSRDLRF318
TP53-PXDNLchr177577499chr852567320972DRB1-0413RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0415RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0417RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0417RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0424RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0424RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0427RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0427RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0429RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0429RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0430RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0430RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0431RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0436RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0439RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0439RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0440RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0441RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0441RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0442RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0443RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0444RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0445RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0445RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0446RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0446RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0447RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0448RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0448RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0449RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0449RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0450RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0450RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0451RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0451RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0452RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0452RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0453RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0454RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0455RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0456RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0457RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0457RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0458RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0459RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0459RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0460RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0460RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0462RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0465RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0465RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0467RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0467RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0467PILTIITLEDSRDLR217
TP53-PXDNLchr177577499chr852567320972DRB1-0467ILTIITLEDSRDLRF318
TP53-PXDNLchr177577499chr852567320972DRB1-0468RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0469RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0470RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0471RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0471RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0473RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0477RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0477RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0478RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0478RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0479RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0480RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0480RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0482RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0483RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0483RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0484RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0484RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0485RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0485RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0486RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0486RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0487RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0487RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0487PILTIITLEDSRDLR217
TP53-PXDNLchr177577499chr852567320972DRB1-0488RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0488RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0489RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0489RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0491RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0491RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-0491PILTIITLEDSRDLR217
TP53-PXDNLchr177577499chr852567320972DRB1-0491ILTIITLEDSRDLRF318
TP53-PXDNLchr177577499chr852567320972DRB1-0803RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0805RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0806RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0810RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0812RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0814RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0818RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0822RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0823RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0827RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0829RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0832RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0833RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0835RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0836RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0837RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0838RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-0840RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-1312RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-1330RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-1358RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-1381RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-1389RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-1410RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-1410RPILTIITLEDSRDL116
TP53-PXDNLchr177577499chr852567320972DRB1-1413RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-1457RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-1473RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-1474RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB1-1478RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB3-0201DSRDLRFNRIREIPG1126
TP53-PXDNLchr177577499chr852567320972DRB3-0204DSRDLRFNRIREIPG1126
TP53-PXDNLchr177577499chr852567320972DRB3-0224DSRDLRFNRIREIPG1126
TP53-PXDNLchr177577499chr852567320972DRB3-0301DSRDLRFNRIREIPG1126
TP53-PXDNLchr177577499chr852567320972DRB4-0101RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB4-0103RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB4-0106RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB4-0107RRPILTIITLEDSRD015
TP53-PXDNLchr177577499chr852567320972DRB4-0108RRPILTIITLEDSRD015

Top

Fusion breakpoint peptide structures of TP53-PXDNL

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
3742IITLEDSRDLRFNRTP53PXDNLchr177577499chr852567320972

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of TP53-PXDNL

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN3742IITLEDSRDLRFNR-7.15543-7.26883
HLA-B14:023BVN3742IITLEDSRDLRFNR-4.77435-5.80965
HLA-B52:013W393742IITLEDSRDLRFNR-6.80875-6.92215
HLA-B52:013W393742IITLEDSRDLRFNR-4.20386-5.23916
HLA-A11:014UQ23742IITLEDSRDLRFNR-7.5194-8.5547
HLA-A11:014UQ23742IITLEDSRDLRFNR-6.9601-7.0735
HLA-A24:025HGA3742IITLEDSRDLRFNR-7.52403-7.63743
HLA-A24:025HGA3742IITLEDSRDLRFNR-5.82433-6.85963
HLA-B27:056PYJ3742IITLEDSRDLRFNR-3.28285-4.31815
HLA-B44:053DX83742IITLEDSRDLRFNR-5.91172-6.94702
HLA-B44:053DX83742IITLEDSRDLRFNR-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of TP53-PXDNL

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
TP53-PXDNLchr177577499chr8525673201221SRDLRFNRICAGAGACTTGAGGTTTAACAGAATAAG
TP53-PXDNLchr177577499chr852567320716ITLEDSRDLCACACTGGAAGACTCCAGAGACTTGAG
TP53-PXDNLchr177577499chr852567320718ITLEDSRDLRFCACACTGGAAGACTCCAGAGACTTGAGGTTTAA
TP53-PXDNLchr177577499chr852567320918LEDSRDLRFGGAAGACTCCAGAGACTTGAGGTTTAA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
TP53-PXDNLchr177577499chr852567320015RRPILTIITLEDSRDGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGAGACTT
TP53-PXDNLchr177577499chr852567320116RPILTIITLEDSRDLGCCCATCCTCACCATCATCACACTGGAAGACTCCAGAGACTTGAG
TP53-PXDNLchr177577499chr8525673201126DSRDLRFNRIREIPGCTCCAGAGACTTGAGGTTTAACAGAATAAGAGAAATTCCAGGGAG
TP53-PXDNLchr177577499chr852567320217PILTIITLEDSRDLRCATCCTCACCATCATCACACTGGAAGACTCCAGAGACTTGAGGTT
TP53-PXDNLchr177577499chr852567320318ILTIITLEDSRDLRFCCTCACCATCATCACACTGGAAGACTCCAGAGACTTGAGGTTTAA

Top

Information of the samples that have these potential fusion neoantigens of TP53-PXDNL

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
SARCTP53-PXDNLchr177577499ENST00000269305chr852567320ENST00000543296TCGA-DX-A7EF-01A

Top

Potential target of CAR-T therapy development for TP53-PXDNL

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to TP53-PXDNL

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to TP53-PXDNL

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource